4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-23-000006
Director acquired 1,568 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anderson Kenneth Carl Director | 2023-01-03 | Grant or award | +1,568 | $6.38 | $10,004 | 94,416 | D: show line 1 in the form |
Loading xslF345X03/wf-form4_167286703601250.xml…